JORGE A BEZERRA
Medical Practice in Cincinnati, OH
License number
Michigan 4301109572
Issued Date
May 10, 2016
Expiration Date
Jan 31, 2020
Category
Medicine
Type
Medical Doctor
Address
Address
Cincinnati, OH 45229
Organization information
See more information about JORGE A BEZERRA at bizstanding.comJorge Bezerra MD
3333 Burnet Ave, Cincinnati, OH 45229
Industry:
Pediatric Gastroenterologist
Phone:
(513) 636-4415 (Phone)
Jorge Abdon Bezerra
Professional information
Jorge A Bezerra, Cincinnati OH
Specialties:
Pediatric Gastroenterologist
Address:
3333 Burnet Ave, Cincinnati, OH 45229
Education:
Universidade Federal do Rio Grande do Norte, Faculdade de Medicina - Doctor of Medicine
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Gastroenterology (Pediatrics), American Board of Pediatrics Sub-certificate in Pediatric Transplant Hepatology (Pediatrics)
Dr. Jorge A Bezerra, Cincinnati OH - MD (Doctor of Medicine)
Specialties:
Pediatric Gastroenterology, Pediatric Transplant Hepatology
Address:
3333 Burnet Ave, Cincinnati 45229
(513) 636-4415 (Phone), (513) 636-7805 (Fax)
Cincinnati Office
3333 Burnet Ave, Cincinnati 45229
(513) 636-4751 (Phone), (513) 636-8145 (Fax)
(513) 636-4415 (Phone), (513) 636-7805 (Fax)
Cincinnati Office
3333 Burnet Ave, Cincinnati 45229
(513) 636-4751 (Phone), (513) 636-8145 (Fax)
Certifications:
Pediatric Gastroenterology, 2010, Pediatric Transplant Hepatology, 2008, Pediatrics, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
U Fed of RG Norte
U Ariz Coll Med
Chldn's Hosp Med Ctr-U Cincinnati
U Fed of RG Norte
U Ariz Coll Med
Chldn's Hosp Med Ctr-U Cincinnati
Jorge Bezerra, Cincinnati OH
Work:
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, Cincinnati, OH 45267
3333 Burnet Ave, Cincinnati, OH 45267
Classification And Diagnosis Of The Molecular Basis Of Cholestasis
US Patent:
2008025, Oct 16, 2008
Filed:
Jan 28, 2008
Appl. No.:
12/011628
Inventors:
Jorge Bezerra - Cincinnati OH, US
International Classification:
C40B 20/04, C07H 21/00, C40B 40/08
US Classification:
506 4, 536 231, 506 17
Abstract:
The methods and compositions of the invention find use in the clinical diagnosis of cholestasis related syndromes, particularly PFIC types 1, 2, and 3; BRIC types 1 and 2; Alagille syndrome, and alpha 1-antitrypsin deficiency. The compositions of the invention include isolated nucleic acid molecules and oligonucleotide pairs suitable for use in amplifying regions of cholestasis related genes. Compositions of the invention include a cholestasis related gene resequencing microarray suitable for determining the nucleotide sequence of a region of a cholestasis related gene. Knowledge of the nucleotide sequence of one or more regions of a patient's cholestasis related gene allows diagnosis of the patient's syndrome.
Classification And Diagnosis Of The Molecular Basis Of Cholestasis
US Patent:
2011007, Mar 24, 2011
Filed:
Oct 14, 2010
Appl. No.:
12/904546
Inventors:
JORGE BEZERRA - CINCINNATI OH, US
International Classification:
C40B 30/00, C07H 21/00, C40B 40/06, C12Q 1/68
US Classification:
506 7, 536 2433, 506 16, 435 6
Abstract:
The methods and compositions of the invention find use in the clinical diagnosis of cholestasis related syndromes, particularly PFIC types 1, 2, and 3; BRIC types 1 and 2; Alagille syndrome, and alpha 1-antitrypsin deficiency. The compositions of the invention include isolated nucleic acid molecules and oligonucleotide pairs suitable for use in amplifying regions of cholestasis related genes. Compositions of the invention include a cholestasis related gene resequencing microarray suitable for determining the nucleotide sequence of a region of a cholestasis related gene. Knowledge of the nucleotide sequence of one or more regions of a patient's cholestasis related gene allows diagnosis of the patient's syndrome.